A STUDENT has told how a revolutionary drug that treats cystic fibrosis saved her from a lung transplant. But last night thousands of sufferers of the killer condition were dealt a blow when NHS England announced it would not provide extra funds for the drug Orkambi, which tackles the genetic causes of the disease rather than treating its symptoms.
Student saved by wonder drug NHS won’t pay for
Post Author: martin
Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now.
He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.